CEFZIL *
Manufacturer Details
BRISTOL LABS INC
Compositions:
Cefprozil 250mg tabs anhy,
Strength
|
Rate
|
Packing Style
|
250mg
|
0.00
|
Tab
|
List of Related Indications:
- Respiratory tract infection
List Of Drugs:
- Cefprozil - Cephalosporins- @ Second generation- (FDC-List) (Dec 1991)
Indication Type Description:
Drug Interaction:
Drugs covered:
1st generation 2nd generation 3rd generation
. Cephalexin Cefaclor Cefixime
Cefadroxil Cefamandole Cefoperazone
Cephadrine Cefotoxitin Cefotaxime
Cephalothin Cefuroxime Ceftizoxime
Cephapirin Cefonicid Ceftriaxone
Cefazolin Cefmetazole Ceftazidime
Cefotetan Ceftibuten
Cefprozil Cefepime
Cefpodoxime
Loracarbef
Refer Cephalosporins
Glucose tests, probenecid Diuretics , other nephrotoxic drugs including aminoglycosides
Indication:
Pharyngitis/tonsilitis
Approved by FDA in December 1991
LIST OF DRUGS DURING 2004
Sr.No- 208
Name of the Drug- Cefprozil Dispersible Tablets 9125mg/250mg)
Pharmacological Classification- Anti-biotic
Date of Approval- 22-06-2004
Approved by U.S.FDA on 30-12-2004 (Ref- FDA approved List- 2004)
LIST OF DRUGS DURING 2006
Sr.No- 1
Name of the Drug- Cefprozil Powder for Oral Supn
(125mg/5ml) Pharmacological Classification- Antibiotic
Date of Approval- 06-01-2006
Approved by U.S.FDA on 30-12-2006 (Ref- FDA approved List- 2006)
LIST OF DRUGS DURING 2007
Sr.No- 184
Name of the Drug- Cefprozil 250mg/500mg +
Clavulanic acid 62.5mg/125mg tablet
Pharmacological classification- For the treatment of adult patients with
upper & lower RTI ,Skin,& Skin structure
infection
,
Date of Approval- 12-11-07
Approved by US FDA on 30-12-2007 (Ref- FDA approved List- 2007)
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1. Cefprozil Antibiotic 10-01-2003
2. Cefprozil 250mg/500mg + 12-11-2007
Clavulanic acid 62.5mg/125mg tablet
For the treatment of Adult patients with upper Lower RTI, Skin
Structure infection
3. Ceprozil dispersible tablets 22-06-2004
125mg/250mg
Antibiotic
4. Cefprozil powder for Oral 06-01-2006
suspension 125mg/5ml
Antibiotic
Adverse Reaction:
GI upset, dizziness, nappy rash, Superinfection, genital pruritus Vaginitis Raises AST, ALT Eosinophillia Clostridium difficile asssociated with diarrhea
Contra-Indications:
Special precautions
Renal impairment Mionitor renal function History of GI disease particularly colitis Discontinue with signs of diarrhea Phenylketonuria Hypersensitivity to penicilins Pregnancy Lactation Labour and delivery
Dosages/ Overdosage Etc:
Approved by FDA in December 1991
Indications: Pharyngitis/tonsilitis
Dosage: Adults- 500mg every 24 hours for 10 days
Children- (2 to 12 years)- 4.5mg/kg/every 12 hours for 10 days
Interaction with Food:
May be taken with meals to reduce GI discomfort